Guidelines for depot antipsychotic treatment in schizophrenia

Comprehensive Textbook of Psychiatry

1967 • 3,952 citations

Influence of Family Life on the Course of Schizophrenic Disorders: A Replication

1972 • 1,769 citations

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1983 • 993 citations

CONDITIONS PREDISPOSING TO SUICIDE

1977 • 510 citations

Relapse in schizophrenia

1980 • 460 citations

Neuroleptic Withdrawal in Schizophrenic Patients

1995 • 436 citations

The Effects of Clozapine on Tardive Dyskinesia

1991 • 304 citations

Depot Antipsychotic Drugs

1994 • 298 citations

Rating of Medication Influences (ROMI) Scale in Schizophrenia

1994 • 274 citations

Low-Dose Neuroleptic Treatment of Outpatient Schizophrenics

1983 • 273 citations

Schizophrenia

1996 • 270 citations

Low- and Conventional-Dose Maintenance Therapy With Fluphenazine Decanoate

1987 • 245 citations

Drug and Sociotherapy in the Aftercare of Schizophrenic Patients

1974 • 241 citations

Dose of Fluphenazine, Familial Expressed Emotion, and Outcome in Schizophrenia

1988 • 241 citations

Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.

1984 • 230 citations

Suicide among Schizophrenics

1984 • 218 citations

Economics and Schizophrenia: The Real Cost

1994 • 216 citations

Intermittent vs Maintenance Medication in Schizophrenia

1991 • 207 citations

Continuous versus targeted medication in schizophrenic outpatients: outcome results [published erratum appears in Am J Psychiatry 1991 Jun;148(6):819]

1990 • 197 citations

Subjective Response as a Predictor of Outcome in Pharmacotherapy

1978 • 189 citations

Tardive Dyskinesia

1993 • 187 citations

Costs and Benefits of Two Doses of Fluphenazine

1984 • 183 citations

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.

1990 • 174 citations

Prospective Study of Tardive Dyskinesia Incidence in the Elderly

1991 • 172 citations

Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication

1982 • 171 citations

Schizophrenia

1981 • 152 citations

Depot neuroleptic therapy: an underutilized treatment option.

1992 • 147 citations

Early Intervention, Time-limited, Targeted Pharmacotherapy of Schizophrenia

1983 • 140 citations

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.

1989 • 134 citations

Long Term Depot Antipsychotics

1994 • 131 citations

Effects of smoking on fluphenazine clearance in psychiatric inpatients

1985 • 117 citations

Subjective response to neuroleptics and the quality of life: implications for treatment outcome

1994 • 116 citations

Double-Blind Comparison of Half-Dose and Standard-Dose Flupenthixol Decanoate in the Maintenance Treatment of Stabilised Out-Patients with Schizophrenia

1987 • 110 citations

A comparative trial of pharmacologic strategies in schizophrenia

1987 • 108 citations

REVIEW OF RAPID URINE TESTS FOR PHENOTHIAZINE AND RELATED DRUGS

1961 • 102 citations

Early Neuroleptic Intervention in Schizophrenia: Are Prodromal Symptoms Valid Predictors of Relapse?

1993 • 99 citations

Quality of Life of Schizophrenic Patients on Medications and Implications for New Drug Trials

1992 • 94 citations

Differences in the Nature of Relapse and Subsequent Inpatient Course between Medication-Compliant and Noncompliant Schizophrenic Patients

1984 • 87 citations

Intermittent versus maintenance neuroleptic long-term treatment in Schizophrenia—2-year results of a German multicenter study

1993 • 84 citations

Prognosis in Schizophrenia

1976 • 81 citations

Studies on serum protein binding of haloperidol.

1977 • 79 citations

The Prevalence and Costs of Psychiatric Disorders and Learning Disabilities

1995 • 73 citations

Quality of life after psychiatric rehabilitation: the clients’ perspective

1991 • 71 citations

A German Multicenter Study on the Neuroleptic Long-term Therapy of Schizophrenic Patients

1986 • 60 citations

Measurement of therapeutic response in schizophrenia

1991 • 54 citations

Compliance in the long-term treatment of schizophrenia.

1985 • 52 citations

Poor neuroleptic response in acutely exacerbated schizophrenic patients

1993 • 49 citations

Family Attitudes and Patient Social Adjustment in a Longitudinal Study of Outpatient Schizophrenics Receiving Low-Dose Neuroleptics: The Family’s View

1988 • 48 citations

Prediction of neuroleptic treatment outcome in schizophrenia : concepts and methods

1994 • 48 citations

Cholinomimetic-induced co-release of prolactin and beta-endorphin in man.

1982 • 38 citations

Prospective study of tardive dyskinesia incidence in the elderly

1991 • 36 citations

Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL.

1990 • 36 citations

Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.

1993 • 34 citations

Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.

1980 • 33 citations

Prediction of Neuroleptic Treatment Outcome in Schizophrenia

1994 • 32 citations

Measurement of compliance.

1985 • 31 citations

Guidelines for the Dosage of Neuroleptics. II

1989 • 30 citations

A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.

1994 • 28 citations

Compliance during tricyclic antidepressant therapy: pharmacokinetic and analytical issues.

1988 • 26 citations

Maintenance treatment of schizophrenia: A review of dose reduction and family treatment strategies

1995 • 25 citations

Treatment strategies in schizophrenia: Effects of dosage reduction and family management on outcome

1993 • 21 citations

How Medication Compliance Affects Outcome

1986 • 21 citations

Dosage Strategies with Long-Acting Injectable Neuroleptics, Including Haloperidol Decanoate

1986 • 20 citations

Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen.

1990 • 19 citations

Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.

1973 • 17 citations

Haloperidol decanoate in chronic schizophrenia: A study of 12 months with plasma levels

1990 • 16 citations

Cost Considerations in the Treatment of Schizophrenia

1996 • 14 citations

The role of dosage and plasma levels in neuroleptic relapse prevention

1994 • 12 citations

Emotional family atmosphere and relapse: investigations on the role of relapse definition, duration of illness and resignation of relatives

1995 • 11 citations

Report on the Fifth Consensus Conference: Methodology of Long-Term Clinical Trials in Psychiatry

1994 • 11 citations

[Domain-specific subjective quality of life and illness-related limitations of chronic schizophrenic patients].

1994 • 10 citations

Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.

1990 • 8 citations

Outpatient Care in Schizophrenia

1994 • 1 citations

Deleted Work

1955 • 0 citations